Searching across hundreds of databases

Our searching services are busy right now. Your search will reload in five seconds.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

Purple sweet potato color attenuated NLRP3 inflammasome by inducing autophagy to delay endothelial senescence.

Journal of cellular physiology | 2019

Autophagy is a vital negative factor regulating cellular senescence. Purple sweet potato color (PSPC), one type of flavonoid, has been demonstrated to suppress endothelial senescence and restore endothelial function in diabetic mice by inhibiting the nucleotide-binding oligomerization domain, leucine rich repeat and pyrin domain containing protein 3 (NLRP3) inflammasome. However, the roles of autophagy in the inflammatory response during endothelial senescence are unknown. Here, we found that PSPC augmented autophagy to restrict high-glucose-induced premature endothelial senescence. In addition, PSPC administration impaired endothelium aging in diabetic mice by increasing autophagy. Inhibition of autophagy accelerated endothelial senescence, while enhancement of autophagy delayed senescence. Moreover, deactivation of the NLRP3 inflammasome triggered by PSPC was autophagy-dependent. Autophagy receptor microtubule-associated protein 1 light chain 3 and p62 interacted with the inflammasome component NLRP3, suggesting that autophagosomes target the NLRP3 inflammasome and deliver it to the lysosome for degradation. Altogether, PSPC amplified cellular autophagy, subsequently attenuated NLRP3 inflammasome activity and finally delayed endothelial senescence to ameliorate cardiovascular complication. These results suggest a potential therapeutic target in senescence-related cardiovascular diseases.

Pubmed ID: 30585631 RIS Download

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

This is a list of tools and resources that we have found mentioned in this publication.


β-Actin Antibody (C4) (antibody)

RRID:AB_2714189

This monoclonal targets β-Actin

View all literature mentions

Beclin-1 (2A4) Mouse mAb (antibody)

RRID:AB_11178656

This monoclonal targets Beclin-1

View all literature mentions

LC3B Antibody (antibody)

RRID:AB_915950

This polyclonal targets LC3B

View all literature mentions

NALP3 Antibody (antibody)

RRID:AB_11189153

This monoclonal targets NALP3

View all literature mentions

SQSTM1/p62 Antibody (antibody)

RRID:AB_10624872

This polyclonal targets SQSTM1/p62

View all literature mentions

NALP3 Antibody (antibody)

RRID:AB_11189153

This monoclonal targets NALP3

View all literature mentions

Beclin-1 (2A4) Mouse mAb (antibody)

RRID:AB_11178656

This monoclonal targets Beclin-1

View all literature mentions

SQSTM1/p62 Antibody (antibody)

RRID:AB_10624872

This polyclonal targets SQSTM1/p62

View all literature mentions

β-Actin Antibody (C4) (antibody)

RRID:AB_2714189

This monoclonal targets β-Actin

View all literature mentions

LC3B Antibody (antibody)

RRID:AB_915950

This polyclonal targets LC3B

View all literature mentions